Article
Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer: a comprehensive cancer center experience.
BMC cancer - 10 Feb 2026
Abdel-Razeq Hikmat, Saleh Yacob, Hani Hira Bani, Abdel-Razeq Rashid, Mohamad Issa, Sharaf Baha, Tamimi Faris, Abu-Jaish Hala, Al-Atary Areej, Aljabri Anisa, Alnajjar Rahaf, Sammour Mohammd, Ghanem Ameed, Amarin Rula, Awabdeh Tala
Abstract excerpt
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths worldwide. Between 5% and 10% of PDACs are attributable to inherited genetic alterations, identification of which may enhance targeted screening and inform treatment decisions. Data on germline variants among Arab patients with PDAC are lacking. METHODS: This prospective study included adult patients with PDAC treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
